Colgate-Palmolive Company (NYSE:CL) Vice Chairman Franck J. Moison sold 35,000 shares of the firm’s stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $71.52, for a total value of $2,503,200.00. Following the transaction, the insider now owns 201,411 shares of the company’s stock, valued at approximately $14,404,914.72. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Shares of Colgate-Palmolive Company (NYSE CL) traded down 0.06% during midday trading on Tuesday, hitting $71.70. The company had a trading volume of 1,909,282 shares. The company has a 50-day moving average of $73.49 and a 200-day moving average of $72.60. The company has a market capitalization of $63.16 billion, a PE ratio of 26.64 and a beta of 0.80. Colgate-Palmolive Company has a 12 month low of $63.43 and a 12 month high of $77.27.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.72. The business had revenue of $3.83 billion for the quarter, compared to analysts’ expectations of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The company’s revenue for the quarter was down .5% compared to the same quarter last year. During the same period last year, the firm earned $0.70 earnings per share. Analysts predict that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Tuesday, July 18th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.23%. The ex-dividend date of this dividend is Friday, July 14th. Colgate-Palmolive’s payout ratio is currently 59.48%.

ILLEGAL ACTIVITY WARNING: This story was first reported by American Banking News and is the property of of American Banking News. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at https://www.americanbankingnews.com/2017/08/08/colgate-palmolive-company-cl-vice-chairman-sells-2503200-00-in-stock.html.

Several research firms have weighed in on CL. UBS AG restated a “neutral” rating and set a $78.00 price target (down previously from $79.00) on shares of Colgate-Palmolive in a report on Tuesday, May 2nd. Royal Bank Of Canada restated a “hold” rating and set a $74.00 price target on shares of Colgate-Palmolive in a report on Monday, April 24th. Jefferies Group LLC began coverage on Colgate-Palmolive in a report on Tuesday, April 18th. They set a “hold” rating and a $78.00 price target for the company. BidaskClub cut Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Saturday, June 24th. Finally, Wells Fargo & Company restated a “market perform” rating on shares of Colgate-Palmolive in a report on Monday, July 24th. Two research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $75.82.

Hedge funds have recently made changes to their positions in the stock. Burke & Herbert Bank & Trust Co. raised its position in Colgate-Palmolive by 0.5% in the first quarter. Burke & Herbert Bank & Trust Co. now owns 7,020 shares of the company’s stock valued at $514,000 after buying an additional 37 shares during the period. Creative Planning raised its position in Colgate-Palmolive by 2.7% in the first quarter. Creative Planning now owns 101,951 shares of the company’s stock valued at $7,462,000 after buying an additional 2,716 shares during the period. Raymond James Trust N.A. raised its position in Colgate-Palmolive by 10.1% in the first quarter. Raymond James Trust N.A. now owns 21,407 shares of the company’s stock valued at $1,567,000 after buying an additional 1,968 shares during the period. Northstar Group Inc. raised its position in Colgate-Palmolive by 0.4% in the first quarter. Northstar Group Inc. now owns 4,850 shares of the company’s stock valued at $356,000 after buying an additional 20 shares during the period. Finally, Indiana Trust & Investment Management CO acquired a new position in Colgate-Palmolive during the first quarter valued at approximately $218,000. Institutional investors and hedge funds own 73.85% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.